Trupanion (NASDAQ:TRUP) Trading Up 10.5%

Trupanion, Inc. (NASDAQ:TRUPGet Free Report) shot up 10.5% during trading on Monday . The company traded as high as $22.80 and last traded at $21.93. 346,862 shares changed hands during mid-day trading, a decline of 49% from the average session volume of 677,940 shares. The stock had previously closed at $19.85.

Wall Street Analyst Weigh In

Several research analysts recently commented on TRUP shares. Piper Sandler reduced their target price on Trupanion from $28.00 to $22.00 and set a “neutral” rating for the company in a research report on Friday. Stifel Nicolaus raised their price objective on shares of Trupanion from $25.00 to $28.00 and gave the stock a “hold” rating in a report on Friday, February 16th. Canaccord Genuity Group lowered their target price on shares of Trupanion from $40.00 to $34.00 and set a “buy” rating on the stock in a research note on Friday. Finally, Evercore ISI cut their price target on shares of Trupanion from $35.00 to $31.00 and set an “outperform” rating for the company in a research note on Tuesday, February 20th. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $29.40.

Check Out Our Latest Report on Trupanion

Trupanion Price Performance

The stock has a market capitalization of $945.19 million, a P/E ratio of -35.45 and a beta of 1.76. The company’s 50 day simple moving average is $25.61 and its two-hundred day simple moving average is $26.72. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.62 and a quick ratio of 1.63.

Trupanion (NASDAQ:TRUPGet Free Report) last released its quarterly earnings results on Thursday, May 2nd. The financial services provider reported ($0.16) EPS for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.02. Trupanion had a negative return on equity of 9.03% and a negative net margin of 2.31%. The business had revenue of $306.12 million for the quarter, compared to analyst estimates of $300.51 million. During the same period in the prior year, the company earned ($0.60) EPS. Trupanion’s revenue for the quarter was up 19.4% on a year-over-year basis. As a group, equities analysts expect that Trupanion, Inc. will post -0.43 EPS for the current fiscal year.

Institutional Investors Weigh In On Trupanion

Hedge funds have recently added to or reduced their stakes in the stock. SG Americas Securities LLC acquired a new position in Trupanion during the 3rd quarter worth $261,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Trupanion by 35.6% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,011 shares of the financial services provider’s stock valued at $254,000 after acquiring an additional 2,367 shares during the last quarter. BluePath Capital Management LLC acquired a new stake in Trupanion in the third quarter worth about $31,000. Nisa Investment Advisors LLC boosted its stake in shares of Trupanion by 108.9% in the 3rd quarter. Nisa Investment Advisors LLC now owns 18,930 shares of the financial services provider’s stock valued at $534,000 after purchasing an additional 9,869 shares during the last quarter. Finally, Check Capital Management Inc. CA raised its stake in shares of Trupanion by 32.1% during the third quarter. Check Capital Management Inc. CA now owns 22,925 shares of the financial services provider’s stock worth $646,000 after buying an additional 5,575 shares during the last quarter.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Read More

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.